strong beat/rais pipelin progress continu buyer weak
buyer weak broader biotech sector drag
cover tyler van buren today think pressur macro-
driven compani specif point note solid beat
rais continu pipelin progress increas certainti regard complement
inhibit franchis revenu tail much remain like name would
continu recommend purchas stori continu improv leadership
new manag team far shown impress execut
solid beat/commentari post one strongest beat long time non-
ep soundli beat consensu pjc revenu
well ahead consensu pjc soliri drove upsid
beat revenu consensu pjc driven mostli uptak
newly-label gmg gener myasthenia gravi indic commentari
gmg shape best launch soliri indic strong word
consid success seen pnh ahu
rais seem conserv revenu guid higher
midpoint midpoint rais ep guid higher midpoint
midpoint rais oper margin guid higher bp rais
investor express disappoint us light magnitud beat
fact new guidanc bracket consensu see cfo paul clanci
typic mo howev doubt alxn last guidanc rais year
constern survey feedback see misplac
doc would switch some/al soliri patient field investor
question concern doc wont switch view concern entir
prematur price reimburs logist consider yet
determin gain full approv pnh ahu gmg
numer tool affect number switch scenario
fire cylind buyer right see today weak transient
buy opportun front continu beats/rais estim remain ahead
guidance/consensu detail herein well increasingli clear pictur
revenu tail much longev bear might appreci given remain
buyer pt
commerci regulatori clinic ip risk associ market pipelin product
alexion develop market therapi address rare diseas
discount back
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
updat model follow updat revis guidanc includ
moder soliri estim given time tender order etc
revenu estim increas guid rang
ep estim ahead guid rang
price target remain deriv use multipl previous appli
ep estim discount back think slightli lower
multipl warrant given volatil space though impact lower multipl off-set
partial laps discount period
page
collabor agreement
good sold
product sale
total revenu
sell gener administr
total revenu
statement oper
dollar except per share data
provis incom tax tax benefit
current disclosur inform compani locat http //www piperjaffray com/researchdisclosur
